Biophysical Properties of 9 KCNQ1 Mutations Associated With Long-QT Syndrome by Yang, Tao et al.
Ping Yang, Jonathan R. Skinner, Dan M. Roden and Mark I. Rees
Jackie Crawford, Judith MacCormick, Carey-Anne Eddy, Andrew N. Shelling, John K. French, 
Tao Yang, Seo-Kyung Chung, Wei Zhang, Jonathan G.L. Mullins, Caroline H. McCulley,
 Mutations Associated With Long-QT SyndromeKCNQ1Biophysical Properties of 9 
Print ISSN: 1941-3149. Online ISSN: 1941-3084 
Copyright © 2009 American Heart Association, Inc. All rights reserved.
Avenue, Dallas, TX 75231
is published by the American Heart Association, 7272 GreenvilleCirculation: Arrhythmia and Electrophysiology 
doi: 10.1161/CIRCEP.109.850149
2009;2:417-426; originally published online May 22, 2009;Circ Arrhythm Electrophysiol. 
 http://circep.ahajournals.org/content/2/4/417
World Wide Web at: 
The online version of this article, along with updated information and services, is located on the
  
 http://circep.ahajournals.org//subscriptions/
is online at: Circulation: Arrhythmia and Electrophysiology  Information about subscribing to Subscriptions:
  
 http://www.lww.com/reprints
 Information about reprints can be found online at: Reprints:
  
document. Answer
Permissions and Rights Question andunder Services. Further information about this process is available in the
permission is being requested is located, click Request Permissions in the middle column of the Web page
Clearance Center, not the Editorial Office. Once the online version of the published article for which 
 can be obtained via RightsLink, a service of the CopyrightCirculation: Arrhythmia and Electrophysiologyin
 Requests for permissions to reproduce figures, tables, or portions of articles originally publishedPermissions:
 at Cardiff University on February 19, 2014http://circep.ahajournals.org/Downloaded from 
Biophysical Properties of 9 KCNQ1 Mutations Associated
With Long-QT Syndrome
Tao Yang, PhD; Seo-Kyung Chung, BSc; Wei Zhang, MS; Jonathan G.L. Mullins, PhD;
Caroline H. McCulley, PhD; Jackie Crawford, NZCS; Judith MacCormick, MBChB;
Carey-Anne Eddy, MSc (Med); Andrew N. Shelling, PhD; John K. French, MBChB, PhD;
Ping Yang, PhD; Jonathan R. Skinner, MBChB, FRACP, FRCPCH, MD;
Dan M. Roden, MD; Mark I. Rees, PhD, FRCPath
Background—Inherited long-QT syndrome is characterized by prolonged QT interval on the ECG, syncope, and sudden
death caused by ventricular arrhythmia. Causative mutations occur mostly in cardiac potassium and sodium channel
subunit genes. Confidence in mutation pathogenicity is usually reached through family genotype-phenotype tracking,
control population studies, molecular modeling, and phylogenetic alignments; however, biophysical testing offers a
higher degree of validating evidence.
Methods and Results—By using in vitro electrophysiological testing of transfected mutant and wild-type long-QT
syndrome constructs into Chinese hamster ovary cells, we investigated the biophysical properties of 9 KCNQ1 missense
mutations (A46T, T265I, F269S, A302V, G316E, F339S, R360G, H455Y, and S546L) identified in a New
Zealand–based long-QT syndrome screening program. We demonstrate through electrophysiology and molecular
modeling that 7 of the missense mutations have profound pathological dominant-negative loss-of-function properties,
confirming their likely disease-causing nature. This supports the use of these mutations in diagnostic family screening.
Two mutations (A46T, T265I) show suggestive evidence of pathogenicity within the experimental limits of biophysical
testing, indicating that these variants are disease-causing via delayed- or fast-activation kinetics. Further investigation
of the A46T family has revealed an inconsistent cosegregation of the variant with the clinical phenotype.
Conclusions—Electrophysiological characterization should be used to validate long-QT syndrome pathogenicity of novel
missense channelopathies. When such results are inconclusive, great care should be taken with genetic counseling and
screening of such families, and alternative disease-causing mechanisms should be considered. (Circ Arrhythmia
Electrophysiol. 2009;2:417-426.)
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Long-QT syndrome (LQTS) is a potentially fatal arrhyth-mic syndrome typically associated with a prolonged QT
interval on the surface 12-lead ECG. It represents a diverse
range of disorders associated with prolonged ventricular
repolarization.1 Current estimates are that LQTS mutation
carriers can be present in 1 in 1000 to 5000.2,3 Recent
advances in the molecular basis of LQTS have revealed a
greater than expected incidence within the population caused
by the extent of incomplete penetrance within families with
causative potassium and sodium cardiac ion channel genes.4,5
More recently, LQTS and the allelic SCN5A disorder, Bru-
gada syndrome, have been strongly associated with a propor-
tion of sudden unexpected death syndrome cases, including in
infancy.6
Clinical Perspective on p 426
To date, 10 genes have proven association with LQTS:
LQT1 (KCNQ1) and LQT2 (HERG) encode -subunits of the
voltage-gated K channel, IKs and IKr, respectively; LQT3
(SCN5A) encodes the -subunit of a voltage-gated Na
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channel; LQT5 (KCNE1) and LQT6 (KCNE2) code for the
-subunit of IKs and IKr, respectively; and LQT4 (Ankyrin-B)
is a member of a membrane adapter protein family.7 Recently,
the Andersen (KCNJ1) and Timothy (Cav1.2) syndrome genes
have been suggested as loci for LQT7 and LQT8, respectively.8,9
Voltage-gated K channels require 4 -subunits with 6
transmembrane domains (S1–S6), a voltage sensor (S4), a
pore loop containing a conserved K-selective signature
sequence between S5 and S6, and 1 -subunit to form a
functional ion channel.
Several LQTS genetic screening studies have been pub-
lished identifying more than 600 mutations that have revealed
important pathophysiological mechanisms of arrhythmogen-
esis.3,10,11 Pathological mutations in these channel subunits
can reduce the depolarizing/repolarizing cardiac current
through several mechanisms, including allelic haploinsuffi-
ciency, heterotetrameric dominant-negative mechanisms,
nonsense-mediated decay, and trafficking defects.12,13 Al-
though the outcome of mutations that cause frameshift RNA
messages and truncated polypeptides are generally unequiv-
ocal, the novel and recurrent missense variants are more
problematic, as observed in many other genetic disorders.14 It
is imperative that genotype pathogenicity is convincing to
assign a degree of assurance that family cascade testing is
truly informative. This has led to a trend in clinical and
scientific best practice in which variants are determined to be
mutations of pathological significance by using both larger
control cohorts with ethnic stratification and electrophysio-
logical testing of missense mutations. In response to this, we
tested the biophysical properties of 5 novel and 4 literature-
recurrent KCNQ1 mutations that were detected in a genetic
screening program.15 We demonstrate that 7 of the missense
mutations we assayed and modeled have pathological
dominant-negative properties that abolish IKs dynamics. Two
novel mutations that are phylogenetically conserved and
excluded from the control population have alternative expla-
nations in which we present suggestive data on the mecha-
nism of abnormal receptor activity.
Methods
Patients and Cases
The cases were referred to tertiary cardiac arrhythmia clinics for a
variety of reasons. Most patients had experienced syncope or
resuscitated sudden cardiac death. This study also included 8 patients
previously diagnosed with epilepsy who had exhibited prolonged or
borderline QTc intervals on ECG examination and 4 surviving
parent-pairs of young children who were victims of sudden cardiac
death. Informed consent for genetic testing was obtained in all cases
as established in the multicenter ethics approval protocols covering
this project (Auckland Regional Ethics Committee). DNA was
extracted from blood samples using standard phenol-chloroform
extraction.
Mutation Detection
The mutations have been described previously15,16 and were discovered
by denaturing high-performance liquid chromatography (dHPLC) anal-
ysis of LQTS genes in index cases. Any sample that displayed a variant
chromatogram profile was selected for further analysis by DNA se-
quencing. Purified DNA fragments were sequenced using Big Dye
Terminator kits and an ABI 3100 automated sequencer (Applied
Biosystems, Foster City, Calif) at the Centre for Gene Technology,
University of Auckland. Population frequency of single-nucleotide
polymorphisms or mutations were assessed in 300 control chromosomes
as well as data from other screening studies and database sites. Various
Genebank databases were aligned with LQTS gene families and
homologs at the point of mutation to assess the degree of evolutionary
conservation.
Site-Directed KCNQ1 Mutagenesis and Transient
Transfection in Chinese Hamster Ovary Cells
The human KCNQ1 DNA was originally provided by Dr Mark
Keating (currently at Novartis Institute of Biomedical Research,
Cambridge, Mass). Individual KCNQ1 mutation constructs were
made using a QuikChange XL site-directed mutagenesis kit and
manufacturer instructions (Stratagene Inc, La Jolla, Calif). The
human IKs channel auxiliary subunit KCNE1-IRES-pEGFP construct
was a gift from Dr Al George at Vanderbilt University. All inserts
were sequenced to ensure that only the desired mutation was
obtained. Wild-type or mutated KCNQ1 constructs and KCNE1 (at
1:1 g ratio) were transiently cotransfected into cultured Chinese
hamster ovary cells with FuGENE6 transfection reagent (Roche
Applied Science, Indianapolis, Ind). A plasmid encoding the en-
hanced green fluorescent protein (pEGFP) linked to KCNE1 was
used to identify transfected cells for the voltage clamp studies. Cells
were grown for 48 hours after transfection before study.
Whole-Cell Voltage Clamp Studies and Solutions
Whole-cell voltage clamping was performed at room temperature
with 3 to 5 mol/L patch microelectrodes and an Axopatch 200A
amplifier (Molecular Devices, Sunnydale, Calif). The cell chamber
(extracellular) solution contained (in mmol/L) NaCl 145, KCl 4.0,
MgCl2 1.0, CaCl2 1.8, glucose 10, and HEPES 10; the pH was 7.4,
adjusted with NaOH. The pipette (intracellular) solution contained
(in mmol/L) KCl 110, MgCl2 1.0, ATP-K2 5.0, BAPTA-K4 5.0, and
HEPES 10; the pH was 7.2, adjusted with KOH. Data acquisitions
were done by use of pClamp9.2 (Axon Instruments Inc), sampled at
1 kHz, and low-pass–filtered at 5 kHz. Activating current was
elicited with 5-second depolarizing pulses to 60 mV from a
holding potential of80 mV at a 10-mV increments, and tail current
was recorded on return to 40 mV. Pulses were delivered every 30
seconds. To mimic a “physiological” action potential duration, a
single 400-ms pulse to 20 mV and back to 40 mV for another
100 ms from the holding potential of 80 mV was used to compare
the initial IKs magnitudes in wild-type and several particular KCNQ1
mutant channels in some experiments. To determine the membrane
potential of the channels activated, I-V relationships were established by
fitting data to the Boltzmann equation: IImax/{1exp[(VtV0.5)/k]},
where Imax is the maximal current, Vt is the testing potential, V0.5 is the
membrane potential at which 50% of the channels are activated, and k
is the slope factor. Current densities (pA/pF) were obtained after
normalization to cell surface area calculated by Membrane Test
(OUT 0) in pClamp9.2. The steady-state activating current at the end
of a 5-second depolarizing pulse to 60 mV and the peak deacti-
vating tail current at 40 mV were measured for comparisons of
wild type (WT) with mutated IKs densities. The time constants (Tau,
ms) for activating IKs currents in WT and any mutations with
obvious channel gating changes were obtained by using the Cheby-
shev method to fit individual activating current traces to the
monoexponential function: A1*exp{(t-k)/tau}C.
Statistical Analysis
Data are expressed as meanSEM. For comparisons among means
of several groups, ANOVA was used, with post hoc pairwise
comparisons by Duncan test if significant differences among means
were detected. If only 2 groups were being compared, Student’s t test
was used. A probability value of 0.05 is considered statistically
significant.
Structural Modeling
The locations of the newly identified KCNQ1 mutations were
investigated using the recently published homology model of the
transmembrane regions of the open and closed KCNQ1 channel in
418 Circ Arrhythmia Electrophysiol August 2009
 at Cardiff University on February 19, 2014http://circep.ahajournals.org/Downloaded from 
tetrameric form.17 All models were visualized using the molecular
graphics program Chimera (http://www.cgl.ucsf.edu/chimera/).
Results
LQTS Cases
All 9 patients with 5 novel and 4 literature-recurrent KCNQ1
mutations selected for functional analysis had Romano-Ward
syndrome, an autosomal dominant hereditary disorder char-
acterized by a prolonged QT interval on the ECG, syncope,
and sudden death. The heart rate–corrected QT interval (QTc)
ranged from 480 to 660 ms (average, 53420 ms). Eight
patients were of European descent, and 1 was of Maori descent.
The presenting clinical features are indicated in Table 1. Three
cases were identified from follow-up of sudden unexpected
death in a first-degree family member.
Novel KCNQ1 Mutations in LQTS
Between 2001 and 2005, 48 gene-positive probands were
identified in an LQTS screening program in New Zealand15:
25 had KCNQ1 mutations, 9 of which (in 2004) had not been
reported in the literature (see Table 1). Subsequently, 4 of the
variants (A46T, A302V, G316E, and S546L) have been
reported by other LQTS screening programs but without any
supporting electrophysiological data, whereas there are alterna-
tive amino acid substitutions or frameshifts recorded at positions
265 (T265fs 22X), 302 (A302T), and 360 (R360T).10,18
Therefore, all 9 variants described here are novel observations
based on receptor properties recorded by in vitro functional
electrophysiology. Sequence analysis revealed that these muta-
tions are located in a variety of domain regions in KCNQ1
(Figure 1): the N terminus (A46T), S5 (T265I), the S5 and P
loop linker (F296S), the P loop (A302V and G316E), S6
(F339S), and the C terminus (R360G, H455Y, and S546L).
Population studies confirmed that these sequence variations
were not represented in unrelated controls, and phylogenetic
alignment of KCNQ1 homologs confirmed that the mutations
have occurred at conserved sites. Mutation constructs of
KCNQ1 were prepared using a QuikChange XL site-directed
mutagenesis kit and submitted for electrophysiological
characterization.
Seven KCNQ1 Mutations Are
Loss-of-Function Channels
To compare the biophysical properties of normal IKs with
those of the KCNQ1 subunit mutations, we used single
5-second pulsing to60 mV from a holding potential of80
Table. KCNQ1 Gene Variants Characterized in the Study
Sequence Variants and
Amino Acid Changes Protein Position Age, y Sex Ethnicity Syncope
SCD of First-Degree
Relative RSCD Identified Trigger/s QTc, ms
136GA: A46T N-terminal 57 F European Y Y Stress 620
794CT: T265I S5 40 F European Y Y Rest/sibutramine 660
887TC: F296S S5/pore 14 F European 490
905CT: A302V Pore 12 F Maori Y Exercise/stress 490
947GA: G316E Pore 8 M European Y Y* Exercise (water) 560
1016TC: F339S S6 9 M European Y Y Exercise 480
1078AG: R360G C-terminal 15 F European Y Exercise (water) 600
1363CT: H455Y C-terminal 38 F European Y 470
1637CT : S546L C-terminal 9 M European Y Exercise (water) 480
Representation of novel/recurrent KCNQ1 variants and phenotypic presentation of the index patients (refer to Reference 15).15 The patients presented with syncope,
resuscitated sudden cardiac death (RSCD), or as surviving parents of sudden cardiac death (SCD) in young children. All were subsequently identified as having
Romano-Ward Syndrome (RWS) by presentation of QT-interval elongation and mutations in KCNQ1 (LQT1).
*DC cardioversion required.
Figure 1. Positioning of the KCNQ1 vari-
ants on a 2-D representation of the
KCNQ1 channel protein subunit domains.
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mV to elicit the IKs current. The tail current was recorded on
return to 40 mV. WT KCNQ1 and the auxiliary subunit
KCNE1 were first coexpressed to generate an outward potas-
sium current typical to cardiac IKs current (Figure 2A).
Individual KCNQ1 mutations were then studied with KCNE1
coexpression for comparison. As illustrated in Figure 2 and
Figure 3A and B, 7 of the 9 KCNQ1 mutations generated a
reduced IKs current when coexpressed with KCNE1. The IKs
magnitudes by the other 2 mutations (A46T and T265I) were
similar to normal IKs, except that A46T-IKs showed a fast
activation (Figure 2B): the time constants for activation at
60 mV were 1717.3192.4 ms (WT) and 977.668.9 ms
(A46T-IKs, P0.01, n6 cells for each group), respectively.
The half-maximal voltage (V0.5) of IKs activation was not
different among WT, A46T, T265I, G316E F339S, and
H455Y (P0.05) (Figure 3C). However, the V0.5 for the
mutation F296S was 10 mV more negative than WT-IKs
(P0.05), whereas the V0.5 for S546L was significantly
shifted toward a more positive direction (20 mV greater
than WT-IKs, P0.01). Because of very small IKs magnitude
from A302V and R360G, the current-voltage curves for the 2
mutations were not established to generate the V0.5 values.
Enhanced Initial IKs Currents and Loss of the
Delay Phase of the IKs in Particular
KCNQ1 Mutations
In our experiments with a 5-second pulse protocol, we found
that 2 KCNQ1 mutations (A46T and H445 years) activated
more rapidly without an initial delay at the very beginning
phase of the IKs (Figure 2, B and I). In addition, T265I
appears to have a longer delay before the current activation
(Figure 2C). Accordingly, we applied a single 500-ms pulse
protocol that mimics a physiological action potential dura-
tion. In this protocol, a 400-ms depolarization pulse to 20
mV with a 100-ms repolarization to 40 mV was used. The
current magnitudes at 100th- and 400th-ms points were
measured for comparisons. As illustrated in Figure 4A,
WT-IKs showed an initial delay at first 50-ms before
activation (rising phase in dotted box). The mutations A46T-
IKs and H455Y-IKs lost this initial current delay with a rapid
activation/rising phase (Figure 4, B and E). However, the
mutation T265I-IKs displayed a longer delay (150 ms)
before activation (Figure 4D). The summarized data on the
current magnitudes at 100th- and 400th-ms points are pre-
sented in Figure 4, C and F.
Given the fact that the IKs channel is highly upregulated by
-adrenergic stimulation and that the mutation A46T was
located in the N terminus of the KCNQ1 channel, we further
compared the effects of a -receptor agonist isoproterenol
(1 mol/L) on WT-IKs and this mutant. The experimental
results in Figure 4 (G through I) showed that the
-stimulation increased the current in both WT and A46T to
a similar extent, implying that the A46T mutation did not
influence the -stimulation–mediated phosphorylation of the
KCNQ1 channel. Previously, we and others have already
Figure 2. IKs for WT (A) and mutated KCNQ1 constructs (B through J) in the presence of KCNE1 in Chinese hamster ovary cells. Raw
IKs traces were obtained by using the voltage-clamp protocol at room temperature. Cells were clamped to a holding potential of 80
mV. Activating IKs was elicited with a 5-second pulse from 80 to 60 mV, and deactivating tail current was recorded on repolarization
to 40 mV for another 5 seconds.
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demonstrated that several amino acid residues in the N
terminus (S27) and C terminus (S468 and T470) are critical
phosphorylation sites of the KCNQ1 channel.19,20
Two Mutations Have Suggestive Outcomes
There is inconclusive but suggestive evidence for functional
consequences of 2 variants in this study (A46T and T265I)
representing challenges for the clinical interpretation of the
genotype. The mutation C794T (with resulting T265I) was
found in a 40-year-old woman who presented after resusci-
tated sudden death during sleep (Figure 5A). She had been
taking sibutramine, a medication to aid with weight loss, for
approximately 3 weeks before her presentation, and her case
has been previously reported.16 Her QTc was 600 to 660 ms,
and she went on to have an intracardiac cardioverter-
defibrillator inserted. A previous ECG was also abnormal,
with prolonged QTc of 500 ms. Subsequent ECGs have had
QTc values in the upper normal range. She has 4 children who
all have prolonged QTc intervals, 1 of whom has a history of
syncope on exertion. Cascade testing in 3 younger children
has identified the same mutation as the proband, whereas the
oldest child has declined genetic testing. The proband’s
mother and 3 siblings have all had ECGs with normal QTc
intervals. Her father has a prolonged QTc of 0.48 seconds and
is gene-positive.
The mutation G136A (with resulting A46T) has previously
been reported by Napolitano et al.10 In our cohort, it was
detected in a 57-year-old woman after presentation with acute
syncope while taking cisapride (Figure 5B). She had a history
of syncope at times of stress. Her initial QTc interval was 620
ms, whereas subsequent ECGs have revealed QTc intervals of
400 to 470 ms. Her presenting episode of collapse occurred in
the days after the unexpected death of her son, who had died
suddenly, during gentle activity, at 37 years of age. He also
had a history of syncope, but there were no prior ECGs. The
postmortem examination revealed no cause, but no DNA was
available for posthumous genetic screening. Despite the
proband’s presentation, the acutely prolonged QTc interval,
and family history of young sudden death, further investiga-
tion of the family to date lends some doubt as to the
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Figure 3. Summarized data for WT and mutated IKs currents. A, Steady-state IKs current levels for WT and mutations. Currents were
measured at the end of a 5-second depolarizing pulse. B, Peak IKs tail current for WT and mutations. Peak tails were measured after a
5-second repolarizing pulse to 40 mV. C, Half-maximal voltage of IKs activation (V0.5, mV) for WT and mutations. After current-voltage
relations were obtained, the V0.5 values were obtained after fitting individual data points to the Boltzmann equation: IImax/{1exp
[(VtV0.5)/k]}. Two mutations (A302V and R360G) expressed tail currents too small to generate a V0.5 value.
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malignancy of this mutation. The proband has 3 other
children who all have a history of syncope and have under-
gone cascade genetic screening. One son (QTc, 380 to 420
ms) and 1 daughter (QTc, 420 to 480 ms) tested positive for
this mutation; the other daughter (QTc, 420 to 440 ms) had
negative cascade testing. The proband’s 2 living siblings have
not presented for assessment but are reportedly asymptomatic.
Another sibling died in an accident at age 20 years. With regard
to the proband’s parents, her father died at age 71 years, and her
mother’s genetic screening was negative. As a result of the poor
cosegregation of the mutation with clinical findings in this
family, together with the in vitro electrophysiological testing
result, we are not using cascade screening as a definitive test for
the presence or absence of disease in this family.
Molecular Modeling of the KCNQ1 Mutations
The tertiary positions of mutations T265I, F296S, A302V,
G316E, and F339S were examined in relation to the recently
published homology model of the transmembrane regions of
the protein.17 The N-terminal A46T mutation and the
C-terminal R360G, H455Y, and S546L fell outside the current
coverage of published models and crystal structures. A crystal
structure for the C-terminal region of human KCNQ1 has
recently been elucidated,21 but this is restricted to residues 584 to
621 of the C terminus.
As shown in Figure 6A, in the closed state, T265 and F339
are closely located and likely to interact by means of
intrachain hydrophobic interactions between S5 and S6. F296
and A302 are also closely located, but on the extramembrane
portion of the P loop. Comparison of the closed and open
states of the channel (Figure 6A and B) reinforces the
importance of the mutated positions. In the open state, the
interactions between the residues of each pairing are less
intimate, suggesting that engagement and loss of specific
hydrophobic interactions are central to the conformational
changes in the transmembrane and loop regions required for
activity of the channel. We speculate that mutations involving
these residues disrupt the fine architecture of the channel and
preclude normal opening and closure. G316 is located on the
P loop, squarely at the entry to the pore (Figure 6C). The
G316E mutation directly restricts the aperture of the pore by
introducing a much larger and negatively charged glutamic
acid residue to this critical gating position (Figure 6D). It is
also possible that the mutation may bring about misfolding of
Figure 4. Five hundred–millisecond short pulse–elicited currents and responses to isoproterenol (ISO, 1 mol/L). In several particular
KCNQ1 mutations, a voltage-clamp pulsing protocol to 20 mV for 500 ms (corresponding to the plateau membrane potential and
duration of a cardiac action potential, inset) was used to compare further the very beginning (initial) currents. Responses of WT and
mutation A46T to the -adrenergic stimulation by isoproterenol were also compared.
422 Circ Arrhythmia Electrophysiol August 2009
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Figure 5. Pedigrees and clinical data of the gene-positive families with uncertain, ambiguous outcomes. A, Family with KCNQ1 A46T
and associated clinical presentation and incidences. B, Family with T265I and associated clinical presentation and incidences. Refer to
the figure for the key guide.
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the protein, which may subsequently affect its trafficking or
tetramerization, although homology modeling of the E316
variant (data not shown) suggests that this is unlikely.
Discussion
Many KCNQ1 mutations and rare variants have now been
identified in a variety of KCNQ1 domains and regions
(http://www.fsm.it/cardmoc), some of which are recurrent in
populations whereas some remain private to 1 index case or
extended family. This represents a dilemma in the clinical
setting because it is difficult to assign pathogenicity to novel
variants without several levels of validating evidence, the best
of which is the demonstration of biophysical deficits by in
vitro electrophysiological experiments. This is a highly spe-
cialized and challenging technology platform that is unlikely
to cross over to the diagnostic domain; nevertheless, it can
provide definitive evidence and clinical confidence that a
gene variant can translate into a functional mutation.
For this reason, we describe in this study the biophysical
characterization of 9 KCNQ1 variants in patients with
Romano-Ward syndrome.15,16 The gene-positive patients had
unequivocally prolonged QTc intervals, and all but 1 had
typical presentation scenarios such as syncope during exer-
cise, a history of sudden death in the family, or resuscitated
cardiac arrest. Within the KCNQ1 subunit structure, these
mutations are located in different regional domains: the N
terminus (A46T), S5 (T265I), the S5 and P loop linker
(F296S), P loop (A302V and G316E), S6 (F339S), and the C
terminus (R360G, H455Y, and S546L). Four variants (A46T,
A302V, G316E, and S546L) have subsequently been detected
by other LQTS screening programs but without any support-
ing electrophysiological data, whereas there are alternative
amino acid substitutions or frameshifts recorded at positions
265 (T265fs22X), 302 (A302T), and 360 (R360T).10,18
Whatever the status and origin of the KCNQ1 variants, the
biophysical investigation of their pathogenicity has not been
investigated.
The value of discovering the physiological properties of
channel variants has contributed much to the understanding
of the pathophysiological mechanisms of LQTS.12–14 Cardiac
slowly activating delayed rectifier K current (IKs) is gener-
ated by coassembly of the -subunit KCNQ1 (KvLQT1) and
its auxiliary subunit KCNE1 (minK). The IKs current does not
play a major role in regulation of cardiac repolarization under
normal physiological conditions. However, mutations in the
KCNQ1 gene could cause inherited prolongation of the QT
interval by reducing the quality of IKs current, thereby
affecting cardiac repolarization. Expression studies have
demonstrated that LQTS mutations of genes related with K
currents can produce loss of channel function by either a net
current reduction by altering the channel gating and kinetic
Figure 6. The chains of the tetramer shown in blue (a), green (b), lime (c), and red (d). Residues involved in mutations are shown in ball
and stick. A, Closed: The 2 pairings, F296 (gray) and A302 (yellow); T265 (purple) and F339 (black) in close proximity; G316 (orange),
on P loop, projected outward into pore of channel. B, Open: The 2 pairings are drawn apart, and G316 (orange), on P loop, is with-
drawn from the pore of the channel. C, KCNQ1 in open conformation shows the pore region. The G316 WT, with positions of glycine
residues, which possess no side chain, are shown in gray, leaving the channel unobstructed. D, KCNQ1 in open conformation shows
restriction of the pore by the G316E mutation. E316, on P loop, is shown in orange for chains a and c, projected outward into the pore.
For illustration, WT G316, shown in yellow on P loop of chains b and d, leaves the channel unobstructed. All models were visualized
using the molecular graphics program Chimera (http://www.cgl.ucsf.edu/chimera/).
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properties, prevention of assembly of functional channel
protein, or an abnormal intracellular protein trafficking.
We examined the electrophysiological properties of the 9
KCNQ1 mutations in the presence KCNE1 by heterologous
expression in Chinese hamster ovary cells and by using a
whole-cell voltage clamp. We found 7 KCNQ1 mutations
causing a reduced IKs current density with coexpression of
KCNE1, indicating the loss of function in the heterotetramet-
ric state channel. The electrophysiological data for the 7
KCNQ1 mutations with decrease the IKs density suggest
several possible mechanisms: (1) a positive shift of the
channel activation voltage could lead to a reduction of the
current (this effect is more obvious in the mutation S546L);
(2) the dominant-negative effect; and (3) failure of the
channel protein expression within the cell membrane. The
studies relating to the latter 2 effects are separate projects that
are being pursued, but irrespective of the specific mechanism
involved, it is now possible to label these 7 LQTS genotypes
as definitive pathological mutations.
Two other mutations (A46T and T265I) displayed no
alterations in the current density, although there is evidence
that T265I-IKs displayed a longer delay (150 ms) before
activation, and A46T-IKs (as well as H455Y-IKs) lost initial
current delay with a rapid activation/rising phase. In the
mutation T265I, a longer initial 100-ms current delay and
small current magnitude would be responsible for prolonged
QT intervals. Studies have demonstrated that the initial delay
phase of IKs channel activation is caused by its -subunit
KCNE1 via moving the channel through multiple closed
states before opening during a depolarization,22,23 thereby
decreasing the initial current activation. In the cases of
A46T-IKs and H455Y-IKs, whether the interaction between
the mutation and KCNE1 is affected to some degree remains
to be studied further. The mutation-caused loss of delay of the
initial IKs activation could be caused by channel accumulation
in open states between depolarization pulses. The mutation-
caused loss of delay of the initial IKs activation could be
associated with more channel accumulations in Zone 1 of
closed states that are near-open states in the Markov model of
the IKs channel kinetics. The channel accumulation in Zone 1
of closed states between cardiac action potentials provides an
“available reserve”24 that represents an important mechanism
for IKs participation in repolarization and its dependence on
rate. During the action potential repolarization, especially at
fast heart rates, these readily available channels can very
quickly open on demand to cause rapid IKs activation and rise,
an effect to shorten cardiac action potential duration. Again,
the current magnitude at the first 100 ms of IKs activation was
larger in the mutation A46T than in WT current (Figure 4C).
Therefore, these alterations in IKs properties could explain
failure to observe a prolonged QT interval in the A46T
patient.
Structural modeling helps us to conceptualize the different
functional effects of particular mutations. Mutation of T265
and F339 affect interactions between S5 and S6. This is
consistent with the T265I mutation displaying a longer delay
(150 ms) before activation (Figure 4D) as the normal
movements of the S5 helix required for efficient opening and
closure are impeded by the substitution of threonine by the
larger more hydrophobic isoleucine. F339S, on the other
hand, involves substitution by a smaller more polar residue,
which is less physically impeding but nevertheless remains
pathogenic as indicated by the functional assays (Figure 2G).
Although the A302V substitution involves residues of
similar size, the observed functional effects may be caused by
the external aqueous environment being less forgiving of
changes in hydrophobic interactions. Similarly, changes in
polarity of exposed extramembrane residues on mutation
affect V0.5 values, resulting accordingly in more negative
(F296S, change to polar) or more positive S546L (change to
hydrophobic) values. The G316E mutation appears to ob-
struct directly the normal aperture of the pore by introducing
a much larger and negatively charged glutamic acid side
chain to one of the most sensitive gating positions. Modeling
and comparison of the heteromeric mutation of 2 of the 4
chains (Figure 6D) with the WT (Figure 6C) reveal the extent
to which the pore is likely to be obstructed. It is interesting to
note that the mutation also disrupts the second glycine residue
in a combinatorial sequence pattern [S/T]xx[S/T]xG[F/Y]G
that has been identified in 90% of 134 potassium channel
reentrant loops analyzed,25 which suggests that this glycine
residue may also be important for the stable insertion of the
P loop within the membrane.
In summary, the biophysical characterization of these 9
KCNQ1 missense mutations has provided unequivocal het-
erogeneous proof of pathogenicity in 8 variants to support the
various clinical and genetics studies. We remain uncertain as
to the pathogenicity of A46T, given that the suggestive
biophysical evidence and cosegregation studies are inconclu-
sive in part because of resistance to wider family screening.
In this family it is possible that the genetic basis of the QT
prolongation lies elsewhere, and further molecular screening
of the index cases must remain an option. Although cellular
electrophysiological testing is unlikely to move easily into the
clinical diagnostic area, its clinical value is very important
and not in question, given the high proportion of novel
genetic variants being discovered presenting a challenge to
the clinical and genetic counseling teams. For the time being,
a collaborative multidisciplinary approach is needed between
clinical and research domains to permit relative and informa-
tive proof for cardiologists and genetic counseling teams.
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CLINICAL PERSPECTIVE
Long-QT syndrome (LQTS) is characterized by prolonged QT interval on the ECG, syncope, and sudden death caused by
ventricular arrhythmia. Inherited LQTS is caused by mutations in cardiac ion channel genes, and mutation screening in
LQTS is now a well-established part of genetic service programs around the world. Identification of mutations that are
known to cause arrhythmias is useful. The significance of novel mutations is often unclear. Is such a mutation a rare natural
variation in the human genetic code or a pathophysiological entity predisposing to sudden death? This study supports the
use of biophysical testing to provide evidence for functional pathogenicity of such mutations. The protein coded for by the
mutated gene can be expressed in vitro to allow electrophysiological characterization of the resulting ion channels,
providing an indication of the mechanisms by which the clinical phenotype is produced. Electrophysiology analysis
identified dominant negative/loss-of-function properties in 7 of 9 novel LQTS mutations evaluated in this study, supporting
the disease-causing nature of these mutations. These findings support the use of electrophysiological characterization to
potentially validate LQTS pathogenicity of novel missense mutations in ion channels. This approach may be helpful in
assessing risk and providing genetic counseling and screening of families with novel mutations.
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